Shannon T Kelley insider trades: Madrigal Pharmaceuticals (MDGL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shannon reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | MDGL | ↓ Sell | 1,077 | $400.00 | $431K | Direct | Nov 6, 2026 (0d) |
| Aug 17, 2026 | MDGL | ↓ Sell | 664 | $514.97 | $342K | Direct | Aug 20, 2026 (3d) |
| Mar 6, 2026 | MDGL | ↓ Sell | 360 | $431.94 | $155K | Direct | Mar 6, 2026 (0d) |
| Jan 20, 2026 | MDGL | ↓ Sell | 692 | $497.36 | $344K | Direct | Jan 20, 2026 (0d) |
| Aug 18, 2025 | MDGL | ↓ Sell | 1,304 | $367.81 | $480K | Direct | Aug 18, 2025 (0d) |
| Mar 3, 2025 | MDGL | ↓ Sell | 415 | $335.00 | $139K | Direct | Mar 5, 2025 (2d) |
| Jan 17, 2025 | MDGL | ↓ Sell | 277 | $273.41 | $76K | Direct | Jan 17, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDGL insiders
Open-market trades in the last 12 months
About Shannon T Kelley's insider trades
Shannon T Kelley is General Counsel at Madrigal Pharmaceuticals (MDGL). Since Jan 17, 2025, Shannon has reported no open-market purchases and 7 sales worth $2.0M on SEC Form 4. In the last 12 months: 4 sales ($1.3M).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.